Pre-Made Lepunafusp Alfa Biosimilar, Fusion Protein targeting TFRC fused with human IDUA (iduronidase, alpha-L-) isoform 1 via a peptidyl linker: Recombinant therapeutic protein targeting CD71/IMD46/T9/TFR/TFR1/TR/TRFR/p90 is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Lepunafusp alfa is a blood-brain-barrier-penetrating form of recombinant human alpha-L-iduronidase fused to the alpha-L-iduronidase anti-transferrin receptor antibody Fab as pabinafusp alfa. Human alpha-L-iduronidase deficiency causes lysosomal storage disease mucopolysaccharidosis type I which leads to disrupted glycosaminoglycan catabolism.